Early trial tests blood pressure drug for brain energy in dementia
NCT ID NCT04760860
Summary
This early-stage study is testing whether a medication called terazosin is safe and tolerable for people with Lewy body dementia. Researchers will enroll 40 participants to receive either the drug or a placebo for 12 weeks, primarily checking for side effects and drop-out rates. The study also aims to see if the drug can improve brain energy levels, which are often low in this type of dementia, but it is not designed to prove if the drug improves thinking or movement symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa
Iowa City, Iowa, 52252, United States
Contact Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.